These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 25477224)

  • 1. Letter by Sen and Powers regarding article, "Adherence to third European cooperative acute stroke study 3- to 4.5-hour exclusions and association with outcome: data from get with the guidelines-stroke".
    Sen S; Powers WJ
    Stroke; 2015 Jan; 46(1):e15. PubMed ID: 25477224
    [No Abstract]   [Full Text] [Related]  

  • 2. Response to letter regarding article, "Adherence to third European cooperative acute stroke study 3- to 4.5-hour exclusions and association with outcome: data from get with the guidelines-stroke".
    Cronin CA; Smith EE
    Stroke; 2015 Jan; 46(1):e16. PubMed ID: 25477215
    [No Abstract]   [Full Text] [Related]  

  • 3. Adherence to Third European Cooperative Acute Stroke Study 3- to 4.5-hour exclusions and association with outcome: data from Get with the Guidelines-Stroke.
    Cronin CA; Sheth KN; Zhao X; Messé SR; Olson DM; Hernandez AF; Bhatt DL; Schwamm LH; Smith EE
    Stroke; 2014 Sep; 45(9):2745-9. PubMed ID: 25104846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment With Tissue Plasminogen Activator in the Golden Hour and the Shape of the 4.5-Hour Time-Benefit Curve in the National United States Get With The Guidelines-Stroke Population.
    Kim JT; Fonarow GC; Smith EE; Reeves MJ; Navalkele DD; Grotta JC; Grau-Sepulveda MV; Hernandez AF; Peterson ED; Schwamm LH; Saver JL
    Circulation; 2017 Jan; 135(2):128-139. PubMed ID: 27815374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessing the impact of thrombolysis on progress through inpatient rehabilitation after stroke: a multivariable approach.
    Meyer M; Murie-Fernandez M; Hall R; Liu Y; Fang J; Salter K; Foley N; Teasell R
    Int J Stroke; 2012 Aug; 7(6):460-4. PubMed ID: 22264226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of tissue-type plasminogen activator before and after publication of the European Cooperative Acute Stroke Study III in Get With The Guidelines-Stroke.
    Messé SR; Fonarow GC; Smith EE; Kaltenbach L; Olson DM; Kasner SE; Schwamm LH
    Circ Cardiovasc Qual Outcomes; 2012 May; 5(3):321-6. PubMed ID: 22550132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transition of European Cooperative Acute Stroke Study III results to clinical practice: ninety-day outcomes in a US cohort.
    Cronin CA; Langenberg P; Dutta TM; Kittner SJ
    Stroke; 2013 Dec; 44(12):3544-6. PubMed ID: 24092551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expansion of Intravenous Tissue Plasminogen Activator Eligibility Beyond National Institute of Neurological Disorders and Stroke and European Cooperative Acute Stroke Study III Criteria.
    Marchidann A; Balucani C; Levine SR
    Neurol Clin; 2015 May; 33(2):381-400. PubMed ID: 25907912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Letter by Freeman et al regarding article, "Very early mobilization after stroke fast-tracks return to walking: further results from the phase II AVERT randomized controlled trial".
    Freeman WD; Chavez OS; Meschia J
    Stroke; 2011 May; 42(5):e375. PubMed ID: 21474809
    [No Abstract]   [Full Text] [Related]  

  • 10. Rehabilitation outcomes of stroke patients treated with tissue plasminogen activator.
    Meiner Z; Sajin A; Schwartz I; Tsenter J; Yovchev I; Eichel R; Ben-Hur T; Leker RR
    PM R; 2010 Aug; 2(8):698-702; quiz 792. PubMed ID: 20709299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The ECASS 3-hour cohort. Secondary analysis of ECASS data by time stratification. ECASS Study Group. European Cooperative Acute Stroke Study.
    Steiner T; Bluhmki E; Kaste M; Toni D; Trouillas P; von Kummer R; Hacke W
    Cerebrovasc Dis; 1998; 8(4):198-203. PubMed ID: 9684058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. To treat or not to treat? Pilot survey for minor and rapidly improving stroke.
    Balucani C; Bianchi R; Feldmann E; Weedon J; Kolychev D; Levine SR
    Stroke; 2015 Mar; 46(3):874-6. PubMed ID: 25604250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of tissue plasminogen activator in acute ischemic stroke.
    Hatcher MA; Starr JA
    Ann Pharmacother; 2011 Mar; 45(3):364-71. PubMed ID: 21386027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The THRIVE score predicts symptomatic intracerebral hemorrhage after intravenous tPA administration in SITS-MOST.
    Flint AC; Gupta R; Smith WS; Kamel H; Faigeles BS; Cullen SP; Rao VA; Bath PM; Wahlgren N; Ahmed N; Donnan GA;
    Int J Stroke; 2014 Aug; 9(6):705-10. PubMed ID: 25042855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of the extended thrombolysis time window on the proportion of recombinant tissue-type plasminogen activator-treated stroke patients and on door-to-needle time.
    Minnerup J; Wersching H; Ringelstein EB; Schilling M; Schäbitz WR; Wellmann J; Berger K
    Stroke; 2011 Oct; 42(10):2838-43. PubMed ID: 21852612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. World Stroke Day 2016 - "Face the facts: Stroke is treatable".
    Davis S; Norrving B; Lalor E; Brainin M; Hacke W
    Int J Stroke; 2016 Oct; 11(8):844-845. PubMed ID: 28068889
    [No Abstract]   [Full Text] [Related]  

  • 17. Letter by Hill et al regarding article, "A cost-utility analysis of mechanical thrombectomy as an adjunct to intravenous tissue-type plasminogen activator for acute large-vessel ischemic stroke".
    Hill MD; Khatri P; Tomsick TA; Simpson KN; Broderick JP
    Stroke; 2011 Dec; 42(12):e641-2; author reply e643. PubMed ID: 22033994
    [No Abstract]   [Full Text] [Related]  

  • 18. Interdisciplinary rehabilitation outcomes following thrombolysis for acute ischaemic stroke: a case series.
    Finch E; Fleming J; Clark K; Hayward KS
    NeuroRehabilitation; 2014; 35(1):9-16. PubMed ID: 24990002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Thrombolysis in stroke--results of the ECASS study (European Cooperative Acute Stroke Study)].
    Nervenarzt; 1995 Aug; 66(8 Suppl):1-8. PubMed ID: 9131091
    [No Abstract]   [Full Text] [Related]  

  • 20. European Cooperative Acute Stroke Study III: support for and questions about a truly emerging therapy.
    Fisher M; Hachinski V
    Stroke; 2009 Jun; 40(6):2262-3. PubMed ID: 19390068
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.